Emerging biologics in severe asthma

Benzer Materyaller

• Interleukin-5 inhibitors for severe asthma: Rationale and future outlook.
  Yazar:: Shrimanker, R, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Evidence for the efficacy and safety of anti- interleukin-5 treatment in the management of refractory eosinophilic asthma
  Yazar:: Xue, L, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Management and mechanisms of severe eosinophilic asthma
  Yazar:: Shrimanker, R
  Baskı/Yayın Bilgisi: (2020)
• Exacerbations of severe asthma in patients treated with mepolizumab
  Yazar:: Shrimanker, R, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
  Yazar:: Howell, I, ve diğerleri
  Baskı/Yayın Bilgisi: (2024)